HP
MREO

HealthInvest Partners’s Mereo BioPharma MREO Stock Holding History

HealthInvest Partners’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-764,901
Closed -$167K – 43
2025
Q3 		$167K Hold
764,901
– – 0.62% 37
2025
Q2 		$2.07M Buy
764,901
+374,901
+96% +$905K 0.89% 31
2025
Q1 		$878K Hold
390,000
– – 0.39% 34
2024
Q4 		$1.37M Buy
390,000
+190,000
+95% +$746K 0.65% 29
2024
Q3 		$822K Buy
+200,000
New +$827K 0.39% 34

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

HealthInvest Partners's MREO Position: Q4 2025 in Review

HealthInvest Partners sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 764,901 shares — an estimated $167K sold.

HealthInvest Partners first reported a position in MREO in Q3 2024 and held it in 5 quarters. The position peaked at $2.07M in Q2 2025. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • HealthInvest Partners reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • HealthInvest Partners sold 764,901 Mereo BioPharma shares in Q4 2025, an estimated $167K.
  • HealthInvest Partners first reported a position in Mereo BioPharma in Q3 2024 and held it in 5 quarters.
  • HealthInvest Partners's Mereo BioPharma position peaked at $2.07M in Q2 2025.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on HealthInvest Partners's 13F filing for Q4 2025, filed 6 Feb 2026.